Valuation Policy for Venture Funds: ASC 820 Compliance Guide

Most emerging fund managers treat valuation policy as a compliance checkbox. The LPs who've sat through enough capital calls know better — a poorly constructed valuation framework is often the first sign of operational immaturity, and it can derail an institutional LP relationship before it ever gets started.

Getting your venture fund valuation policy right isn't just about satisfying your auditor. It's about building credibility with sophisticated LPs, navigating SEC expectations, and creating a defensible, repeatable process for one of the most subjective exercises in finance: determining what a private startup is worth today.

This guide walks through ASC 820 compliance requirements for venture funds, practical fair value methodologies, and how to build a valuation policy that holds up under scrutiny.

What Is ASC 820 and Why Does It Apply to VC Funds?

ASC 820, Fair Value Measurement, is the U.S. GAAP standard that governs how entities measure and disclose fair value. For venture capital funds, it's the foundational framework for valuing portfolio company investments on financial statements.

The standard defines fair value as the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date — what's known as an "exit price" concept. This isn't what you paid for the investment, and it isn't necessarily what you hope to get. It's your best estimate of what the market would pay today.

ASC 820 organizes inputs into a three-level hierarchy:

• Level 1: Quoted prices in active markets for identical assets (rarely applicable to VC portfolios)
• Level 2: Observable inputs other than Level 1 prices — comparable transactions, market multiples, or secondary market pricing
• Level 3: Unobservable inputs based on the fund's own assumptions — this is where the vast majority of early-stage venture investments land

Most VC portfolios are almost entirely Level 3, which means the burden of building and defending valuation assumptions falls squarely on the fund manager.

Core Components of a Venture Fund Valuation Policy

Your valuation policy is the formal document that describes how your fund will estimate fair value for each investment type, at each stage, and under each set of circumstances. Institutional LPs expect to see this document before they commit capital. Auditors will hold you to it.

A complete venture fund valuation policy should address the following:

1. Governance and Oversight Structure

The policy must define who is responsible for determining valuations and what checks exist on that process. Best practice — and increasingly a regulatory expectation — is to establish a Valuation Committee that is independent from the deal team responsible for sourcing and managing the investment.

Key elements to document:

• Membership of the Valuation Committee (typically includes at least one independent member for institutional funds)
• Meeting cadence (quarterly is standard for annual financial statement preparation)
• Escalation procedures when valuations are contested internally
• Role of any third-party valuation specialists

The SEC's 2023 Private Fund Adviser Rules heightened scrutiny on conflicts of interest in valuation. While portions of those rules faced legal challenges, the underlying expectation — that GPs separate valuation responsibility from investment decision-making — reflects industry best practice regardless of the regulatory outcome.

2. Valuation Frequency and Triggers

Most funds value their portfolios quarterly for LP reporting purposes, with annual valuations tied to the formal audit cycle. Your policy should also define trigger events that require an off-cycle valuation reassessment:

• A new financing round (up or down)
• Acquisition announcement or merger activity
• Significant revenue or performance deterioration
• Key executive departure
• Material litigation or regulatory action
• Secondary market transaction involving the portfolio company

Documenting triggers protects you in both directions. It ensures you're not ignoring negative signals, and it creates a record showing you responded appropriately when circumstances changed.

3. Methodologies by Investment Stage

This is the heart of your policy. Different company stages call for different valuation approaches, and ASC 820 requires you to use the method or combination of methods most appropriate to the facts and circumstances.

The IPEV Valuation Guidelines (International Private Equity and Venture Capital Valuation Guidelines) serve as the practical companion to ASC 820 for private markets. Most institutional-grade VC funds align their policies with IPEV, which auditors and LPs recognize as the industry standard.

Common methodologies include:

Price of Recent Investment (PORI) The most common starting point for early-stage deals. When a financing round has recently closed and no material changes have occurred, cost is often the best indicator of fair value. However, "recent" requires judgment — IPEV guidance suggests this approach loses reliability as time passes or circumstances change. Funds typically define a lookback window of 12 to 18 months, after which additional methods are applied.

Market Approach: Comparable Company Multiples For later-stage companies with meaningful revenue, enterprise value can be estimated using revenue or EBITDA multiples from comparable public companies, adjusted for size, growth rate, profitability, and liquidity. The key challenge in venture portfolios is that most startups have negative EBITDA, making revenue multiples the primary anchor. Documenting your comparable company selection rationale is essential — auditors will challenge cherry-picked comps.

Market Approach: Precedent Transactions Acquisition prices for comparable private companies provide another data point. These are harder to source consistently but particularly useful when a portfolio company is approaching acquisition readiness.

Income Approach: Discounted Cash Flow (DCF) Less common in early-stage VC due to the speculative nature of cash flow projections, but appropriate for later-stage companies with predictable revenue models. Discount rates for venture-backed companies are typically in the 25–45% range depending on stage and risk profile, though these should be grounded in market participant assumptions rather than fund-specific views.

Option Pricing Model (OPM) and Probability-Weighted Expected Return Method (PWERM) These equity allocation methodologies are particularly relevant when the portfolio company has a complex capital structure — multiple share classes with different liquidation preferences, participation rights, or conversion features. Rather than applying a company-level value directly to your preferred shares, these models allocate enterprise value across the equity waterfall. For most early-stage VC portfolios, OPM is the standard approach.

Your policy should specify which methodology is the primary approach for each stage category (seed, Series A/B, growth, pre-exit) and define when secondary methods are used to corroborate the primary estimate.

Handling Down Rounds and Impairment

One of the most uncomfortable aspects of portfolio valuation — and one of the most important — is how your policy addresses deteriorating investments.

A down round is relatively straightforward: a new financing at a lower price per share typically triggers a fair value adjustment. The PORI methodology applies, and the new round price serves as the starting point for the equity allocation analysis.

More nuanced is the company that hasn't raised a new round but is clearly underperforming. Your policy must address how you identify and document impairment when there's no new transaction to anchor the analysis. Common indicators include:

• Revenue significantly below plan for two or more consecutive quarters
• Runway falling below six months without a clear financing path
• Loss of a major customer representing more than 20% of revenue
• Failure to achieve key product or regulatory milestones

For these situations, many funds use a calibration approach — starting from the last round price and adjusting based on how the company's performance and market comparables have evolved since then. The adjustment is qualitative-plus-quantitative: document the specific performance gaps and tie them to a revised enterprise value or comparable set.

The worst outcome in a portfolio valuation — for LP trust and regulatory credibility — is carrying a company at cost for six quarters of missed milestones and then writing it to zero the quarter before the audit. Auditors will ask why the decline wasn't recognized earlier, and the answer "we were optimistic" is not a policy.

Third-Party Valuation Specialists

As funds scale, and particularly as they seek institutional LP capital, third-party valuation specialists become less optional. These firms — Kroll, Duff & Phelps, Valuation Research Corporation, and others — provide independent valuation opinions that auditors can rely on and that LPs view as a check on GP self-interest.

There are several common models:

• Full outsourcing: The specialist values the entire portfolio each period
• Periodic independent review: The specialist validates the fund's own valuations annually or for selected holdings
• Spot-check model: The specialist reviews a subset of investments, typically the largest positions or those with the most complex structures

For emerging managers raising their first institutional fund, engaging a third-party specialist for at least the annual audit cycle signals operational maturity. Costs vary significantly — full portfolio coverage for a 20-company fund might run $30,000–$80,000 annually depending on complexity — but the LP credibility benefit typically outweighs the expense.

LP Reporting and Disclosure Requirements

Your valuation policy creates the foundation for LP reporting, but the policy itself should address what gets disclosed and how.

Standard quarterly reporting to LPs should include:

• Fair value of each portfolio investment
• Cost basis
• Unrealized gain/loss
• Level classification (almost always Level 3 for VC)
• A brief narrative on any significant valuation changes

For annual audited financial statements under GAAP, the footnotes must describe your valuation policy, the techniques used, and quantitative information about significant Level 3 inputs — including the range and weighted average of key assumptions like revenue multiples or discount rates. This is not optional disclosure; ASC 820's tabular rollforward and sensitivity disclosures are required.

Some institutional LPs — particularly fund-of-funds and endowments — will also request access to your full valuation policy document as part of due diligence. Having a clean, current policy document ready reduces friction in those conversations.

Common Mistakes Emerging Managers Make

Even well-intentioned managers fall into predictable traps with portfolio valuation:

Carrying everything at cost indefinitely. Unless your entire portfolio is seed-stage and less than 18 months old, carrying every investment at cost signals that your valuation process isn't functioning. PORI is a starting point, not a permanent answer.

Using a single methodology for every company. A 12-month-old pre-revenue biotech and a five-year-old Series D SaaS company require fundamentally different valuation approaches. Your policy should acknowledge this.

Inconsistency across periods. Switching methodologies without documented rationale is a red flag for auditors. If you move from a revenue multiple to a DCF, you need to explain why the facts and circumstances justified the change.

Not calibrating to transaction prices. ASC 820 requires that when an observable transaction occurs (a new round, a secondary), you calibrate your valuation model to that transaction and then update assumptions going forward. Skipping this step undermines the entire framework.

Letting the deal team own the valuation. The person who sourced and championed the deal has a natural incentive to be optimistic. Governance structures that separate valuation from deal management exist precisely because of this dynamic.

Building a Policy That Lasts

A strong venture fund valuation policy isn't a document you write once and file away. It should be reviewed annually, updated when methodologies change or new investment types are added to the portfolio, and stress-tested during each audit cycle.

The funds that build institutional-quality valuation infrastructure early — clear governance, documented methodologies, consistent application, and appropriate third-party oversight — are the ones that close larger LPs, get through due diligence faster, and avoid the regulatory and reputational exposure that comes from valuation disputes.

---

Key Takeaways

• ASC 820 requires venture funds to measure portfolio investments at fair value using an exit price concept — cost basis is rarely sufficient as a long-term approach
• Most VC investments are Level 3, meaning methodology and assumption quality are entirely the fund's responsibility
• A complete valuation policy covers governance, frequency, trigger events, methodology by stage, and impairment criteria
• IPEV Guidelines are the industry-standard companion to ASC 820 — align your policy with them
• Third-party valuation specialists are increasingly expected by institutional LPs and can be engaged at various levels of involvement
• Common errors — carrying everything at cost, inconsistent methodology, deal-team-controlled valuations — are avoidable with the right policy infrastructure in place